发明名称 |
Serpinc1 iRNA compositions and methods of use thereof |
摘要 |
The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of Serpinc1 and methods of treating subjects having a bleeding disorder, such as a hemophilia. |
申请公布号 |
US9376680(B2) |
申请公布日期 |
2016.06.28 |
申请号 |
US201514806084 |
申请日期 |
2015.07.22 |
申请人 |
Alnylam Pharmaceuticals, Inc. |
发明人 |
Akinc Akin;Sehgal Alfica;Toudjarska Ivanka;Foster Donald;Milstein Stuart;Bettencourt Brian;Maier Martin;Charisse Klaus;Kuchimanchi Satyanarayana;Rajeev Kallanthottathil G.;Manoharan Muthiah |
分类号 |
C12N15/113 |
主分类号 |
C12N15/113 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Zacharakis Maria Laccotripe;Nagle Deborah L. |
主权项 |
1. A double-stranded ribonucleic acid (dsRNA) agent for inhibiting expression of Serpinc1, wherein said dsRNA agent comprises a sense strand and an antisense strand, the antisense strand comprising a region of complementarity which comprises at least 21 contiguous nucleotides differing by no more than 1 nucleotide from the nucleotide sequence of 5′ -UUGAAGUAAAUGGUGUUAACCAG-3′ (SEQ ID NO:562),
wherein the antisense strand comprises at least one phosphorothioate internucleoside linkage and a 3′ overhang of at least 1 nucleotide, wherein all of the nucleotides of the sense strand and all of the nucleotides of the antisense strand are modified nucleotides, wherein the nucleotide modifications are selected from the group consisting of 2′—O—methyl (2′-OMe) and 2′-fluoro nucleotide modifications, and wherein a ligand comprising an N-acetylgalactosamine (Ga1NAc) derivative is conjugated to the 3′ end of the sense strand of the dsRNA agent. |
地址 |
Cambridge MA US |